Join the HotCopper ASX share market. Created with Sketch. Created with Sketch. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 48. All ETFs by Morningstar Ratings Morningstar Medalist Rating Gold. 409118. A correctly formatted example follows: Title of my presentation for the conference. To make matters worse he has AZD0466 on hold through no fault of the dendrimer technology, which appears to be highly successful in dealing with the drugs toxicity. I was astounded to see that you Jackie were rewarded with a$200,000 bonus during this time. Time to put your feet up and kick back for a while. Even Pfizer won’t comment on him. Created with Sketch. Latest Posts. Created with Sketch. Last updated 15. municipal. Phillip Altman is a highly-respected and well-known Australian authority on clinical trials and drug regulatory affairs with more than 40 years of experience in designing, managing and reporting of clinical trials and in working with the Australian Therapeutic Goods Administration (TGA) in gaining new drug approvals. . The 407730 is a sound level meter that measures from 40 to 130dB with an accuracy of 2dB. 52 (16th Feb) on the back of the hype that surrounded the launch of VIRALEZE in UK/EU/WORLD. ASX - Short. Click for more information. The purpose of many of us working in pharmaceutical research and development whether within the industry or academia is to deliver medicines to improve the lives of patients around the world. The recent announcement about Viraleze nasal spray going into production in Jan 2021, trying to hit the Euro markets in q1-q2 2021, caused a stir in the SP. 1029/9/2000 SPL $0. com Investors: Chas Cook — 336-436-5076 Investor@Labcorp. Last updated 15. The lab that is. leaves 13+ million shares that were sold by someone else (maybe FIL or AG ??). 2:00 am Eastern Standard Time Australia. Last updated 15. Each to their own. 3¢ STARPHARMA HOLDINGS LIMITED - Discussion. NEVER - there should be an official corruption enquiry considering the Gov Funding and R&D reimbursements recieved by SPL and what actually was achieved and why they haven't been succesful - there's US companies flogging Povidine Iodine nasal spray and throat sprays left right and centre. Do they actually work day in day out? Do research everyday? If so why after 20 years we are still at phase 1/2. Forex. With EOFY selling about to hit us like a freight train, where does everyone think the bottom will be for SPL' shareprice?Unless one of the many promises. Is this a case of short memories? The best one can say is her surprise is disingenuous. The CEO chose to drop a throwaway line at the end of her presentation to potential investors as reported by Antibotter ie “ Starpharma are pursuing registration in China for Viraleze “ as one of if not the biggest market in the world one would think this is a price sensitive comment after all it was said as bait to potential investors. VivaGel BV/Fleurstat was for many years touted as being a company maker in it’s own right. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). ASX - General. ASX - By Stock. There were 17,468,532 shares dumped on Monday 18/10 and as per M & G notice today only 4,359,271 shares were from M & G on Monday. I saw that some director etc invested there own money in the SPP etc,. Starpharma (SPL) Shares in the nano-biotechnology group bucked the falls in the wider market on Monday after it announced a deal with a division of US pharmaceutical giant Ely Lilly to extend the application of its technologies in the animal health area. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). ASX - By Stock. Hope that SPL starts to deliver on its promises. Share It's confusing isn't it So what we have in pre-clinical trials Dep Docetaxel has been used in combination with Gemcitabine Dep Cabazitaxel has been used in combination with GemcitabineReading the TGA decision to fine Starpharma re Viraleze in 2021, and the requirement that SPL apply for approval of Viraleze as Medicine not Medical Device which has been the approval category in many other jurisdictions, I understand from questions I asked at the November 2022 AGM that SPL paid the fine and were concerned that there. 63. Add SPL (ASX) to my watchlist (20min delay). If they have poster data now it shoud be released to shareholders especially since they have used qualifying words such as good etc etc . Unusual to make that announcement?. Forex. That won’t be a shock to. This is a charting thread for those interested in the movements of the SPL SP. ASX - By Stock. Market Cap $77. I was hoping for. Maybe some positive news coming out of Starpharma CEO's busines trip to America over coming daysFor shareholder it is a task of getting a CEO who can make hard decisions based on what does happen but with shrinking internal candidates progress it triggered red flags for me a sif you were very confident and could show progress and efficacy new candidated would and could be funded / partnered so IMO odd to close down or delay. 8985. 53pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on SUNRISE ENERGY METALS LIMITED. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. . A sad state of affairs IMO. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. I sold out of my position in SPL at that time precisely because of this. Magnum Mining and Exploration Limited is an Australia-based company (ASX: MGU), which is engaged in mineral exploration and project development in Nevada, US. I'd think that SPL will be covering all the bases required for a crack at 505b2, but with the necessary data to pivot to a phase 3 trial if. Announcement on LinkedIn today from Prof David Owen that has left SPL after 15years as VP. . Volume. This is what faces SPL's DEP product business, and so far they seem incapable of fighting through the maze to get recognised and accepted. Share Interesting and positive early pre-clinical results. Can anybody load up the most recent Bell Potter Analysis on SPL? I am unable to source it thanks. 8. “If humans respond in a similar way, the benefits of treatment. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. MarketDep Cabazitaxel will be licenced out before initiation of Phase 2 clinical trial (in other words this year. The last time was December 2018. The only double standard I see is that if any employee in the real world repeatedly told their boss that a project would definitely be delivered, every year since 2018 and the project has still not been delivered in early 2023 then they would be ceremoniously SACKED. 00%. 19/09/23. Join the HotCopper ASX. ASX - General. And somebody must be buying all the shares that are being sold. 13. m. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. . 0¢. New Zealand Dollar. ASX - Day TradingSPL buy back distribution agreement , LLoyds hand it back or SPL formally takes action for the agreement to be cancelled due to a default in obligations. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . . 0¢ Sentiment: Buy. Market . Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Share It is now 2 years and 8 months since CEO Jackie Fairley bought any shares in her own company on-market. Interesting write-up. Volume. 0834. 32 , that is a daily rise of over 50% on the market capital at the time it hit that low. 45K. Your post is very vague in its relationship somehow with spl, but the intent of the constant negative narrative is obvious. Good luck to all. Join the HotCopper ASX share market forum today for free. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. 52pm 13/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Today it closes up 5% on the high of the bar and all we here. Market . Starpharma is a world leader in the development of new medical products based on its proprietary dendrimer technology and has partnerships with leading global companies, including AstraZeneca, MSD (Merck & Co. . OR no reponse at all. ca/pst. . The main difference between shareholders and the board and their illustrious leader seems to be just in use of English language, small discrepancies like "well advanced" might me to you or I an agreement is pending, can be expected shortly, what it means to Jackie it would seem is she has undertaken a google search to see who might sell a product such as Viraleze in an particular country. opportunities galore IMO but we are likely to miss the boat again based on past performance of JF & Co. Created with Sketch. If only we had the viraleze. Join the HotCopper ASX share market forum today for free. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. Market . Toll free: 1-877-388-4440 Email: CTBTaxQuestions@gov. Below are 3 charts showing the predictions for Starpharma's Price by End 2019. 38. 615, today the share price rose by 0. Volume. Model # 407730 Store SKU # 1000846365. Hey, "smart", I concur with your message. SUBMISSION STEPS. Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer model (BT474). Stay informed on the day’s latest market trends and receive exclusive access to HotCopper’s trending analysis with inside stories from TMH to help you make sense of what’s happened and navigate what’s ahead. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. ASX - By Stock. 43pm 10/11/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. 15667. Share Interesting points John Some institutions might accept anything over $1. 5¢. I remember seeing a post on SPL had 41000 views. Last edited by sarge17 : 19/09/20 SPL Price at posting: $1. So much coming up with Viraleze and DEP Starpharma team will be working very hard at the moment with so many balls in the air. 5¢. This is a charting thread for those interested in the movements of the SPL SP. ASX - General. The recent announcement about Viraleze nasal. 49M. Click for more information. Join the HotCopper ASX share market forum today for free. SPL conducts a "trial" (use that word loosely) in of all places WA !! Yet our commercial hotshots cannot arrange a deal with a WA based company who appear highly capable and connected in getting distribution to sought after sectors like "Allied Health practitioners, the corporate sector and government". 1. To be fair the ASX has made tries on 3 recent contracts to squeeze information from SPL when didn’t want to disclose how immaterial the contracts is. Hey, "smart", I concur with your message. Forums. Resolutons 2,3 &4. $0. I know that Company's have to concentrate on the task at hand but an awareness of the World Economy is important. $0. Share I sometimes wonder if they actually work at Starpharma. m. So SPL have written responses to shareholders saying Viraleze is avaliable under existing exclusive deal with LLoyds but for some unknown reason SPL have developed a " dedicated VIRALEZE™ product UK webstore" and "other online channels" conveniently at a time when LLoyds seem to have destocked stores and webstore no. SPL could announce tomorrow that DEP doesn’t work and they’ll still find a way to spin it positively. We have oft heard the CEO brag about the $1B+ value of the AZD0466 milestones and license revenues. Advertise on HotCopper. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 1. Furthermore the shameful and disappointing thing is that some pumpers on this forum were encouraging newbies (even when the SP hit its $2. 8¢. Hope that SPL starts to deliver on its promises. Join the. 2327/7/2021 CSL $292. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Latest Posts. SPL have put a lot of time and energy into Docetaxel and Cabazitaxel over many years but it is Irinotecan that seems to be wining the race, probably benefiting from the accrued knowledge from the Doc and Cab trials. GLTAH but for me SPL is still a strong AVOID until a development of substance is announced. $0. HotCopper is Australia's largest free and independent stock market trading forum for ASX share prices & stock market discussions. Join the HotCopper ASX share market forum today for free. and as I said I met @Domesticgod there, which was a pleasure. My understanding is this condition has not been met however each KMP has received 191,152 rights for this alongside other staff whose allocation will no doubt vary according to the capacity of their employment. 0¢ Sentiment: None Disclosure: Held LikesThe CEO seemed to exude a certain excitement in her interview with Alan Kholher have never seen her like that it was bubbling underneath every time she spoke about Viralease. 43M. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. StarPharma Holdings Ltd. 4¢. SPL Ann: Application for quotation of securities - SPL SPL starpharma holdings limited Ann: Application for quotation of securities - SPL ASX News 851. 0¢. LEADING THE BATTERY METALS REVOLUTION. Friday 26/06/2020 looks like the slide deck is very similar if not identical to last Friday's audio presentation I will be recording audio just in case this audio presentation is differentSPL management team get bad marks for delays all the time but I don’t read anyone citing possible reasons. 00 and $5. 76. IMO the Starpharma HQ kool-aide would be tasting pretty bitter these days. Hey, "smart", I concur with your message. FDA, TGA, MHRA to pick fights and get knocked out and 2 blood noses. Market . Latest Posts. The borders are now open Look forward to a positive outcome with new partnership agreements permeating from our team networking at ASCO. Forums. I will be unable to listen to the AGM but look forward to listening to the audio and reading Hotcopper comments and feed back after my afternoon shift. Hey, "smart", I concur with your message. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Just sayin'. IMO they haven't . ASX - By Stock. Feb 28 (Reuters) - Starpharma Holdings Ltd (SPL) : HY REVENUE FROM CONTINUING OPERATIONS DOWN 16% TO A$1. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. 36pm 23/11/2023 ? HotCopper has news, discussion, prices and market data on SPARC TECHNOLOGIES LIMITED. Prior to the trial results being released SPL need to get on the front foot. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. 48. Eight (8) contributors to the HC SPL thread made price predictions (thank. Target our investor. Created with Sketch. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. . Starpharma AGM Summary (Part 1) Oh. $0. and the Government Medical Research Fund which provided $1mil to SPL to aid in developing Viraleze. 54pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on BETMAKERS TECHNOLOGY GROUP LTD. ASX - General. Some days I wondered if I'd see 91c again, but when the Vivagel phase 3 announcement came out I loaded up big time. 0 Created with. )” ~@antibotter Jan 2019 (Hotcopper post #37005569) After ASX announcement ‘Positive DEP phase 2 interim results in prostate cancer’:Peak of the UK Flu season looks to have passed . J K Fairley $1,272,084N J Baade. Become a member of Australia's largest investment discussion forum. ASX - By Stock. Yes I am sure @sarge17 some will come on here today that have been predicting a $2 share price for more than 6 months because it has finally hit that target today saying “I toldNotification of cessation of securities - SPL. 0. m. There is potentially a multi-bagger upside if there was an exceptionally good news announcement. Target our investor community with our suite of Hotcopper. DJPIN. 57. Market . Created with Sketch. The matter has been adjourned to. The SP must break out of the. Share New future tech coming Antibody fragment-nanoparticle therapeutic eradicates cancerPosted YesterdayA multi-institutional team of researchers found novel cancer therapeutic, combining antibody fragments with molecularly engineered nanoparticles, permanently eradicating gastric cancer in treated mice. When a board member uses rheir own hard earned cash and buys $350,000 worth of shares. municipal. Eight (8) contributors to the HC SPL thread made price predictions (thank. AB you'd better start going out on Friday nights and liveing it up to get in practice for the celebrations when SPL hits the big time! SPL Price at posting: $1. We love cruising, but this multi billion dollar industry has effectively been shut down. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be resolved. SPL polylycine dendrimers are proving to play a major role in the future of ADC’s. If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. Just to make sure we are all on the same page as far as AZD0466 is concerned The data available from the AACR SCLC Abstract (April 19th 2023) was from January 24th 2023 (it is out of date by more than 3 months)Fresh off the press 10th May 2023 The NHL trial is accelerating at a rapid rate Fyi 23 sites recruiting out 29 locations Since last update 8 additional. 00%. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Created with Sketch. SPL. The bait SPL have put out about models and publishing in 3 weeks should be stopped by ASX / ASIC and teh timing is odd IMO. 0¢ STARPHARMA HOLDINGS LIMITED - Discussion. Hotcopper has reinvented itself as The Market Herald with an ASX code of TMH The company has an online news site called The Market Herald Below is a. Starpharma are 4+ years from their CRL for Vivagel and we really are none the wiser of what is going on apart from a snippet in the AGM presentation stating 'we. 48. Well done SPL and Scripps Institute. 03% or subsequently a decrease in shorts of. This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. Canadian Dollar. However, I think that maybe SPL is occasionally worth a swing trade gamble. Created with Sketch. Investors and the ASX now have their eye on SPL like they normally would have on dodgy mining penny stocks. . Enquire Now & Supercharge Your Brand with HotCopper 17 Oct 2023. ASX - Day TradingThe short position has been negligible in Starpharma since we go booted from the ASX300 and the shorts were able to cover a large portion of their position at rock bottom share prices in the re-balance. Share lol @col69 the phrase "in parallel we are continuing discussions with potential commercial partners" is now etched into SPL's manual for any asx announcements or releases to the public. Join the HotCopper ASX share market forum today for free. . 375% 0. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. While the chart is not good there is a glimmer hope maybe emerging. You not understand how clinical trials works - it takes years to build regulatory packanage and do CMC. Created with Sketch. Virtual investor presentation Tomorrow night Starpharma will be Participating in a virtual investorpresentation on the OTC website for those that are. ” ~@sarge17 Last edited by sarge17 : 24/02/23 SPL Price at posting: 54. 0¢ Sentiment: None Disclosure: Not HeldHi FolksIts a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. That's how markets work sometimes. All IMO this highlights the problems with agreements where there is seemingly no min order quantity and obligation to advertise and promote the product. . Forums. by other companies i meant those associated with SPL, and ask what up from their end. . Advertise on HotCopper. 5. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. . It would be nice to have SPL make an announcement to the market to clear up the uncertainty around the many market sensitive announcements made that seem to have just faded into the background with no update as to whether they are progressing or if they have ceased. Views. . . But the products were developed as proof of a saleable dendrimer product. Last updated 14. 8¢. 0¢ STARPHARMA HOLDINGS LIMITED - Corporate Spotlight . Twenty years later it’s 84. Attached link highlights some of the complexities involved more broadly. I am STILL inviting comment on SPL and their Zika proclamations, and how this is evidence of SPL’s long standing crumb throwing method. Comments. Join the HotCopper ASX share. . Merck -- 2. Actually I worked for a research firm that supplied SPL with online medical literature and patent research back in the early 2000s. Charts. The real story is SPL hasn't been 63 cents since 24/3/2020 that's not a 52-week low, that's a 114-week low! 2 years 3 months since its seen that price. I have today made my own enquiries with AstraZeneca directly on 1-877-240-9479 and they (Camellia) have confirmed that this trial is not yet recruiting and she also confirmed that the day recruitment starts the status on the website will be updated. 70. We had a Dec 2021 DCB of around the FIB 23. 52 (16th Feb) on the back of the hype that surrounded the launch of VIRALEZE in UK/EU/WORLD. Commodities. ASX - Day Trading. 63. It is now more than ever that SPL needs to communicate with the market and keep everyone informed of any updates, because the radio silence and smoke and mirrors approach is evidently NOT WORKING. 0. Created with Sketch. Advertise on HotCopper. Share Many media conferences during the Pandemic we heard of Victorian initiatives for covid treatments or preventative by Dan Andrews or Brett Sutton - so VICTORIA has questions to answer. Market Cap $57. My portfolio has risen 95% since I sold SPL with conviction. . The sycophants, pompom-wavers, management apologists, cheerleaders and perennial uprampers of SPL on a Hotcopper know who they are. See All Discussions. ASX - By Stock. I think SPL are very worried on what a potential class action could implicate. Taking Cols scenario for a sting like buyout if the buyout price is higher than the highest price the company has reached there is no avenue for complaint. 14. 22%) 3,361,416 was the lowest point of total short sales for some years as of 15/06/23 (0. Talk with one of our capital. Shouldn’t company have announced departure of key person when. Quarterly Activities Report & Appendix 4CLooking further into the AGM notice, Resolution 3 is a massive slap in the face to share holders!!!Basically the company is proposing to dish out a bonus. Target our investor community with our suite of Hotcopper Advertising opportunities. Click for. Join the HotCopper ASX Stock discussion forum for STARPHARMA HOLDINGS LIMITED. ASX - Day TradingShare Can you point out what you believe are their failings with respect to regulatory filings for a "medical device"? Also do you consider that government and regulatory sentiment may have had an impact on consumer demand and any advertising plan - its clear that Governments are still fixated on Vaccination to the disregard of any. Since September 2020 the. Created with Sketch. . Notification of cessation of securities - SPL. 2. Target our investor community with our suite of Hotcopper Advertising opportunities. ASX - By Stock. Join the HotCopper ASX share market forum today for free. Market Cap $55. ASX - By Stock. . Can you imagine. 8¢. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . ASX - Short Term Trading. Labcorp Contacts: Media: Michele Mazur — 336-436-8263 Media@Labcorp. Join the HotCopper ASX share market forum today for free. A trader who used stock forum HotCopper to pump and dump about 20 penny stocks using 13 trading accounts has been given a jail term of 2½ years, but is being released immediately on a five-year. podcasts, and hotcopper) Reading announcements from Starpharma and having to decipher what is actually being said And finally, lacking the ability to sell our products currently. 8¢. . " Indeed. However, just a word of caution before the usual pumping starts by the usual suspects. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . . The AGM has come and gone What did we learn from this meeting according to our attendee's who post on HotCopper forum When it comes to. Join the HotCopper ASX share market forum today for free. 16,364,160. Forums. Created with Sketch. Share So I am guessing nothing came from the Merck meeting Jackie given they were promoted by name in the Shareholder Update on 3 June as a big meeting to be held on the USA holiday ASCO trip and they have been a 'partner' (and I use that term lightly with this mob) for 10 months longer than Genentech so Merck's research should be much further advanced IMO there’s money to be made trading SPL but I do not believe in holding, hoping, trusting and loving SPL at all. ASX - By Stock. 06 Sentiment: Buy Disclosure: Held Created with Sketch. Created with Sketch. There have been so many market sensitive announcements made and then ZEROfollow up on these announcements. 578296.